JP2022544380A5 - - Google Patents

Info

Publication number
JP2022544380A5
JP2022544380A5 JP2022508590A JP2022508590A JP2022544380A5 JP 2022544380 A5 JP2022544380 A5 JP 2022544380A5 JP 2022508590 A JP2022508590 A JP 2022508590A JP 2022508590 A JP2022508590 A JP 2022508590A JP 2022544380 A5 JP2022544380 A5 JP 2022544380A5
Authority
JP
Japan
Prior art keywords
inventions described
inventions
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2022508590A
Other languages
English (en)
Japanese (ja)
Other versions
JP2022544380A (ja
JP7846613B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2020/045442 external-priority patent/WO2021030198A1/en
Publication of JP2022544380A publication Critical patent/JP2022544380A/ja
Publication of JP2022544380A5 publication Critical patent/JP2022544380A5/ja
Priority to JP2025207566A priority Critical patent/JP2026079821A/ja
Application granted granted Critical
Publication of JP7846613B2 publication Critical patent/JP7846613B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2022508590A 2019-08-09 2020-08-07 病原菌を抑制するための組成物及び方法 Active JP7846613B2 (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2025207566A JP2026079821A (ja) 2019-08-09 2025-11-28 病原菌を抑制するための組成物及び方法

Applications Claiming Priority (9)

Application Number Priority Date Filing Date Title
US201962884917P 2019-08-09 2019-08-09
US62/884,917 2019-08-09
US201962901206P 2019-09-16 2019-09-16
US62/901,206 2019-09-16
US201962947517P 2019-12-12 2019-12-12
US62/947,517 2019-12-12
US202063031299P 2020-05-28 2020-05-28
US63/031,299 2020-05-28
PCT/US2020/045442 WO2021030198A1 (en) 2019-08-09 2020-08-07 Compositions and methods for suppressing pathogenic organisms

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2025207566A Division JP2026079821A (ja) 2019-08-09 2025-11-28 病原菌を抑制するための組成物及び方法

Publications (3)

Publication Number Publication Date
JP2022544380A JP2022544380A (ja) 2022-10-18
JP2022544380A5 true JP2022544380A5 (cg-RX-API-DMAC7.html) 2023-08-17
JP7846613B2 JP7846613B2 (ja) 2026-04-15

Family

ID=74571198

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2022508590A Active JP7846613B2 (ja) 2019-08-09 2020-08-07 病原菌を抑制するための組成物及び方法
JP2025207566A Pending JP2026079821A (ja) 2019-08-09 2025-11-28 病原菌を抑制するための組成物及び方法

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2025207566A Pending JP2026079821A (ja) 2019-08-09 2025-11-28 病原菌を抑制するための組成物及び方法

Country Status (5)

Country Link
US (1) US20220409674A1 (cg-RX-API-DMAC7.html)
EP (1) EP4010013A4 (cg-RX-API-DMAC7.html)
JP (2) JP7846613B2 (cg-RX-API-DMAC7.html)
CN (1) CN114502183A (cg-RX-API-DMAC7.html)
WO (1) WO2021030198A1 (cg-RX-API-DMAC7.html)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2018365071B2 (en) * 2017-11-09 2025-09-11 Vedanta Biosciences, Inc. Compositions and methods for the treatment of allergy
EP4410954A3 (en) 2017-12-11 2025-01-15 Vedanta Biosciences, Inc. Compositions and methods for suppressing pathogenic organisms
GB202217266D0 (en) * 2022-11-18 2023-01-04 Imperial College Innovations Ltd Anti-biotic-resistant bacteria
EP4687930A2 (en) * 2023-01-30 2026-02-11 Seres Therapeutics, Inc. Use of designed bacterial compositions for infection treatment
WO2024211569A1 (en) * 2023-04-04 2024-10-10 Vedanta Biosciences, Inc. Compositions and methods for treating or preventing clostridium difficile infection, neutropenia, cardiovascular disease, asthma, and/or cancer
AU2025216788A1 (en) * 2024-02-01 2026-08-13 Vedanta Biosciences, Inc. Compositions and methods for decreasing dysbiosis and/or preventing inflammatory bowel disease
EP4663196A1 (en) 2024-06-13 2025-12-17 Helmholtz-Zentrum für Infektionsforschung GmbH Decolonization of pathogenic enterobacteria, such as e. coli and/or klebsiella pneumoniae, from the gut using strains of e. coli

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AUPQ899700A0 (en) * 2000-07-25 2000-08-17 Borody, Thomas Julius Probiotic recolonisation therapy
CA2606289C (en) * 2005-04-18 2015-03-03 The Regents Of The University Of California Antimicrobial therapy for bacterial infections
MX2015006491A (es) * 2012-11-23 2015-12-03 Seres Health Inc Composiciones bacterianas sinergicas y metodos de produccion y uso de las mismas.
EP2951283A4 (en) * 2013-02-04 2017-01-25 Seres Therapeutics, Inc. Compositions and methods
WO2014182635A1 (en) * 2013-05-08 2014-11-13 Baldwin Megan E Biomarkers for age-related macular degeneration (amd)
MA41020A (fr) * 2014-11-25 2017-10-03 Evelo Biosciences Inc Compositions probiotiques et prébiotiques, et leurs procédés d'utilisation pour la modulation du microbiome
KR102658297B1 (ko) * 2016-06-14 2024-04-18 베단타 바이오사이언시즈, 인크. 클로스트리디움 디피실레 감염의 치료
US20180000872A1 (en) * 2016-07-01 2018-01-04 Regents Of The University Of Minnesota Compositions and methods for c. difficile treatment
US20190160114A1 (en) * 2016-07-29 2019-05-30 Isothrive Llc Optimized individualized prebiotic compositions
WO2018042304A1 (en) * 2016-09-02 2018-03-08 Nestec Sa Compositions and methods for modulating gastrointestinal microflora in a canine
WO2018136884A1 (en) * 2017-01-23 2018-07-26 The Regents Of The University Of California Compositions and methods for treating obesity and inducing weight loss
US11633433B2 (en) * 2017-07-18 2023-04-25 Keio University Anti-bacterial composition against TH1 cell-inducing bacteria
EP4410954A3 (en) * 2017-12-11 2025-01-15 Vedanta Biosciences, Inc. Compositions and methods for suppressing pathogenic organisms
EP4294413A1 (en) * 2021-02-18 2023-12-27 Vedanta Biosciences, Inc. Compositions and methods for suppressing pathogenic organisms

Similar Documents

Publication Publication Date Title
JP2021151238A5 (cg-RX-API-DMAC7.html)
JP2023085489A5 (cg-RX-API-DMAC7.html)
JP2022028828A5 (cg-RX-API-DMAC7.html)
JP2022025124A5 (cg-RX-API-DMAC7.html)
JP2023105131A5 (cg-RX-API-DMAC7.html)
JP2022068302A5 (cg-RX-API-DMAC7.html)
JP2021185136A5 (cg-RX-API-DMAC7.html)
JP2020007340A5 (cg-RX-API-DMAC7.html)
JP2023022224A5 (cg-RX-API-DMAC7.html)
JP2023052878A5 (cg-RX-API-DMAC7.html)
JP2021038271A5 (cg-RX-API-DMAC7.html)
JP2020042034A5 (cg-RX-API-DMAC7.html)
JP2025506484A5 (cg-RX-API-DMAC7.html)
JP2021100406A5 (cg-RX-API-DMAC7.html)
JP2021129286A5 (cg-RX-API-DMAC7.html)
JP2020171301A5 (cg-RX-API-DMAC7.html)
JP2020120660A5 (cg-RX-API-DMAC7.html)
JP2021524864A5 (cg-RX-API-DMAC7.html)
JP2022537813A5 (cg-RX-API-DMAC7.html)
JP2024534771A5 (cg-RX-API-DMAC7.html)
JP2024507827A5 (cg-RX-API-DMAC7.html)
JP2020141705A5 (cg-RX-API-DMAC7.html)
JP2022022379A5 (cg-RX-API-DMAC7.html)
JP2023534232A5 (cg-RX-API-DMAC7.html)
IL285040A (en) Robotic, mobile apparatus for treating a room, for example by disinfection